Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.

about

Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.

Item

http://www.wikidata.org/entity/Q55035830

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@en

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@nl

type

Item

label

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@en

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@nl

prefLabel

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@en

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@nl

P1476

Diwu Yanggan capsule improving ...... zed controlled clinical trial.

@en

P2093

Binbin Zhao

http://www.w3.org/2001/XMLSchema#string

Dingbo Lu

http://www.w3.org/2001/XMLSchema#string

Hanmin Li

http://www.w3.org/2001/XMLSchema#string

Jianxun Gu

http://www.w3.org/2001/XMLSchema#string

Jinrong Zhang

http://www.w3.org/2001/XMLSchema#string

Lin Xiao

http://www.w3.org/2001/XMLSchema#string

Lisheng Zhang

http://www.w3.org/2001/XMLSchema#string

Ming Wan

http://www.w3.org/2001/XMLSchema#string

Wangxi Cai

http://www.w3.org/2001/XMLSchema#string

Xiang Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Histological grading and staging of chronic hepatitis

HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.

Pathologic features of chronic hepatitis. A review and update.

Chronic hepatitis B.

Hepatitis B e antigen-negative chronic hepatitis B.

Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection.

Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.

Clinical trial with traditional Chinese medicine intervention ''tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment'' for chronic hepatitis B-associated liver failure.

The herbal compound "diwu yanggan" modulates liver regeneration by affecting the hepatic stem cell microenvironment in 2-acetylaminofluorene/partial hepatectomy rats

P304

1511-1521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29887964

http://www.w3.org/2001/XMLSchema#string

P932

5992542

http://www.w3.org/2001/XMLSchema#string